Juno Therapeutics Analysts Recommendations and Consensus

Juno Therapeutics Inc -- USA Stock  

USD 45.5  1.79  4.1%

The current analyst and expert consensus on Juno Therapeutics is Hold with 7 hold recommendations. The current projected target price consensus is 35.89 with 9 analysts opinions. One of the most common ways Juno Therapeutics Inc analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Juno Therapeutics vendors, executives, and/or customers. Juno Therapeutics recommendation module provides expert sentiment on the projected Juno Therapeutics Inc target price to derive its highest and lowest estimates based on target price standard deviation of 9.739. Please also check Macroaxis Advice on Juno Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Juno Therapeutics Target Price Consensus

Number of Opinions11
Lowered Outlook0
Raized Outlook0
Hold
Macroaxis Recommendation   Exposure   Valuation

Current Price

Juno Therapeutics Market Quote
Low Price43.41Odds
High Price45.95Odds

45.5

Target Price

Analyst Consensus On Target Price
Low Estimate24.0Odds
High Estimate51.0Odds
Number of Analysts9
Standard Deviation9.739

35.888

Juno Therapeutics Analysit Ratings

Average Consensus